What Analysts Are Saying About Stryker Stock
Portfolio Pulse from Benzinga Insights
Analysts have updated their ratings and price targets for Stryker (NYSE:SYK), with an average 12-month price target of $322.43, up from $300.20. The ratings range from 'Hold' to 'Buy', with recent actions including raises and one lower. Stryker's financials show a solid revenue growth rate of 9.6%, a net margin of 14.1%, but below-average ROE and ROA. The company is a major player in medical equipment and has a strong market presence with a market cap above industry average.
December 22, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a mixed but overall positive outlook on Stryker, with an increased average price target of $322.43, indicating potential upside. The company's strong revenue growth and net margin are positive, but concerns about ROE and ROA may temper investor enthusiasm.
The increase in the average price target by analysts suggests a positive sentiment towards Stryker's stock in the short term. The company's solid revenue growth and net margin are likely to be viewed favorably by investors. However, the below-average ROE and ROA could be areas of concern, potentially limiting the stock's upside. The overall positive revisions in analyst ratings and price targets are likely to have a bullish impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100